Global Diabetes Testing Program Market Growth (Status and Outlook) 2024-2030

Global Diabetes Testing Program Market Growth (Status and Outlook) 2024-2030

A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.

The global Diabetes Testing Program market size is projected to grow from US$ 2450 million in 2024 to US$ 3847 million in 2030; it is expected to grow at a CAGR of 7.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Diabetes Testing Program Industry Forecast” looks at past sales and reviews total world Diabetes Testing Program sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetes Testing Program sales for 2023 through 2029. With Diabetes Testing Program sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Testing Program industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Testing Program landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetes Testing Program portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Testing Program market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Testing Program and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Testing Program.

The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Testing Program market by product type, application, key players and key regions and countries.

Segmentation by Type:
HbA1c Test
Finger-prick Test

Segmentation by Application:
Medical Diagnosis
Home Test
Lab Testing

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
HbA1c Test
Finger-prick Test

Segmentation by Application:
Medical Diagnosis
Home Test
Lab Testing

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
LifeScan
Abbott Laboratories
Ascensia
Arkray
I-SENS
Omron
Braun
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Terumo
Sinocare
Acon Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.